Australia grants $450,000 funding boost to fast-track cancer trials

This brings total investments to $975,000.

Australia’s Minns Labour Government is providing a $450,000 funding boost to an Australian-first alliance fast-tracking cancer patients onto early-stage clinical trials.

Bringing total investments to $975,000, the NSW Early Phase Clinical Trials Alliance (NECTA) aims to accelerate trials through a streamlined screening and referral system, requiring only a blood test.

The investment has also helped increase the annual number of trials available from 150 to more than 180 over the past three years.

Since its establishment in 2017, more than 800 patients have been able to access early-stage clinical trials through NECTA.